Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Lexaria Bioscience (LEXX) Depreciation Expense (2017 - 2021)

Lexaria Bioscience's Depreciation Expense history spans 5 years, with the latest figure at $27929.0 for Q2 2021.

  • For Q2 2021, Depreciation Expense fell 0.54% year-over-year to $27929.0; the TTM value through May 2021 reached $112663.0, up 2.36%, while the annual FY2020 figure was $112750.0, 86.21% up from the prior year.
  • Depreciation Expense for Q2 2021 was $27929.0 at Lexaria Bioscience, roughly flat from $27930.0 in the prior quarter.
  • Across five years, Depreciation Expense topped out at $28875.0 in Q3 2020 and bottomed at $375.0 in Q4 2017.
  • The 5-year median for Depreciation Expense is $26195.0 (2019), against an average of $17293.0.
  • The largest annual shift saw Depreciation Expense soared 4200.95% in 2019 before it decreased 1.24% in 2021.
  • A 5-year view of Depreciation Expense shows it stood at $375.0 in 2017, then surged by 327.47% to $1603.0 in 2018, then surged by 1616.28% to $27512.0 in 2019, then increased by 1.52% to $27929.0 in 2020, then changed by 0.0% to $27929.0 in 2021.
  • Per Business Quant, the three most recent readings for LEXX's Depreciation Expense are $27929.0 (Q2 2021), $27930.0 (Q1 2021), and $27929.0 (Q4 2020).